-Diagnostics (CODX) traded down -4.21 % during a 24 hours period ending at 03:48 AM Central Europe on Tuesday 27th. One -Diagnostics stock can currently be bought for about USD 0.55 on popular exchanges. Current supply of -Diagnostics stocks is 7.9 mn. -Diagnostics has a current market capitalization of USD 4.3 mn and approximately USD 154.8 k worth of -Diagnostics was traded on exchanges in the last 24 hours. Since last month end, -Diagnostics has traded -52.52 % down. Simple moving average of last 200 days is at USD 2.31. The highest price of past 52 weeks was recorded at USD 28.11 on 10/28/2025. 52 weeks low was at USD 0.52 on 10/23/2026.
Here is how related stocks have performed in the past 24 hours:
Healthcare Triangle (HCTI) traded down -11.35 % and now trades at USD 6.84. Current market capitalisation for Healthcare Triangle is USD 5 mn.
Cardio Diagnostics (CDIO) traded down -0.88 % and now trades at USD 1.72. Cardio Diagnostics has a market capitalisation of USD 5 mn.
Processa (PCSA) traded down -2.69 % and now trades at USD 1.8. Processa has a market capitalisation of USD 5.1 mn.
Newton Golf (NWTG) traded up 0.44 % and now trades at USD 1.13. Newton Golf has a market capitalisation of USD 5.2 mn.
Longeveron (LGVN) traded up 0.63 % and now trades at USD 1.6. Longeveron has a market capitalisation of USD 5.1 mn.
About -Diagnostics
Co-Diagnostics Inc. is a molecular diagnostics company that specializes in the development, manufacturing, and selling reagents used for diagnostic tests that rely on the detection and analysis of nucleic acid molecules. Additionally, the company offers diagnostic equipment from other manufacturers as self-contained lab systems. Co-Diagnostics markets its products globally, and you can learn more about their offerings by visiting their website at www.codiagnostics.com . The company’s public trading began on the Nasdaq stock exchange on July 12, 2017.
